tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Income Statement

Compare
56 Followers

Climb Bio Income Statement

Last quarter (Q3 2024), Climb Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Climb Bio's net income was $-8.89M. See Climb Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -35.12M$ -45.24M$ -47.23M$ -20.93M$ -7.45M
Operating Income
$ -40.27M$ -45.13M$ -35.67M$ -20.93M$ -7.45M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -35.12M$ -45.24M$ -47.48M$ -20.67M$ -6.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Climb Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis